HIGHLIGHTS
SUMMARY
Langlitz and colleagues wrote about clinically used psychedelic drugs and the possibility of a "moral psychopharmacology" earlier in this journal. In this opinion Article, I want to, first, reflect on the context-dependency from the perspective of recent research on placebo effects, and, second, clarify different meanings of "moral psychopharmacology". Indeed, after neuroscientists began to investigate moral decision-making, pharmacologists also addressed that domain and ethicists speculated about "moral enhancement", the possibility of using drugs to improve people`s moral capacities. But this should be distinguished, in my view, from a "moral psychopharmacology" in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.